pazenir
ratiopharm gmbh - paclitaxel - breast neoplasms - antineoplastic agents - pazenir monotherapy is indicated for the treatment of metastatic breast cancer in adult patients who have failed first-line treatment for metastatic disease and for whom standard, anthracycline containing therapy is not indicated.pazenir in combination with carboplatin is indicated for the first-line treatment of non-small cell lung cancer in adult patients who are not candidates for potentially curative surgery and/or radiation therapy.
pravalo tablets 10 milligram
ratiopharm gmbh - pravastatin sodium - tablets - 10 milligram
pravalo tablets 20 milligram
ratiopharm gmbh - pravastatin sodium - tablets - 20 milligram
pravalo tablets 40 milligram
ratiopharm gmbh - pravastatin sodium - tablets - 40 milligram
simvastatin sh
ratiopharm gmbh - simvastatin - coated tablets - 5 milligram
simvastatin sh
ratiopharm gmbh - simvastatin - coated tablets - 10 milligram
simvastatin sh
ratiopharm gmbh - simvastatin - coated tablets - 20 milligram
simvastatin sh
ratiopharm gmbh - simvastatin - coated tablets - 40 milligram
pravalo 10 milligram tablets
ratiopharm gmbh - pravastatin sodium - tablets - 10 milligram
pravalo 20 milligram tablets
ratiopharm gmbh - pravastatin sodium - tablets - 20 milligram